261 related articles for article (PubMed ID: 31006923)
1. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
[TBL] [Abstract][Full Text] [Related]
2. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
[TBL] [Abstract][Full Text] [Related]
3. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
4. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
[TBL] [Abstract][Full Text] [Related]
6. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
7. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.
Bestwick JP; Wald NJ
PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071
[TBL] [Abstract][Full Text] [Related]
8. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
10. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis.
Prefumo F; Paolini D; Speranza G; Palmisano M; Dionisi M; Camurri L
PLoS One; 2019; 14(6):e0218166. PubMed ID: 31188879
[TBL] [Abstract][Full Text] [Related]
11. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
[TBL] [Abstract][Full Text] [Related]
14. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing.
Pan M; Huang LY; Zhen L; Li DZ
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):536-540. PubMed ID: 30122574
[TBL] [Abstract][Full Text] [Related]
16. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
[TBL] [Abstract][Full Text] [Related]
17. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
18. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.
García-Pérez L; Linertová R; Álvarez-de-la-Rosa M; Bayón JC; Imaz-Iglesia I; Ferrer-Rodríguez J; Serrano-Aguilar P
Eur J Health Econ; 2018 Sep; 19(7):979-991. PubMed ID: 29249015
[TBL] [Abstract][Full Text] [Related]
20. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
